Accessibility Menu
Editas Medicine Stock Quote

Editas Medicine (NASDAQ: EDIT)

$3.69
(3.4%)
+0.12
Price as of October 23, 2025, 1:21 p.m. ET

KEY DATA POINTS

Current Price
$3.69
Daily Change
(3.4%) +$0.12
Day's Range
$3.59 - $3.77
Previous Close
$3.57
Open
$3.69
Beta
2.05
Volume
18,539
Average Volume
2,379,021
Market Cap
321M
Market Cap / Employee
$3.57M
52wk Range
$0.91 - $4.54
Revenue
-
Gross Margin
0.83%
Dividend Yield
N/A
EPS
-$2.85
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Editas Medicine Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
EDIT+8.51%-89.1%-35.81%-80%
S&P+14.5%+93.32%+14.09%+250%

Editas Medicine Company Info

Editas Medicine is a pioneer in gene editing technology. The biotech holds exclusive rights to CRISPR, a mechanism for cutting and pasting changes to DNA at precise locations.

News & Analysis

The Fool has written over 100 articles on Editas Medicine.

Financial Health

General

Q2 2025YOY Change
Revenue$3.58M597.5%
Gross Profit$1.74M292.3%
Gross Margin48.74%225.5%
Market Cap$184.17M-52.0%
Market Cap / Employee$0.75M0.0%
Employees246-7.2%
Net Income-$53.24M21.3%
EBITDA-$23.63M66.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$138.54M115.0%
Accounts Receivable$0.59M141.0%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$66.66M224.9%
Short Term Debt$11.15M-38.7%

Ratios

Q2 2025YOY Change
Return On Assets-79.57%-37.8%
Return On Invested Capital-62.44%-21.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$50.21M17.1%
Operating Free Cash Flow-$50.21M12.0%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book1.600.600.712.95126.17%
Price to Sales4.553.252.694.77-16.75%
Price to Tangible Book Value1.600.600.712.95126.17%
Enterprise Value to EBITDA-0.853.942.80-3.6076.13%
Return on Equity-78.6%-98.1%-140.8%-188.6%208.01%
Total Debt$38.49M$35.03M$31.13M$77.81M101.06%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.